SARS-CoV-2 Infection and Emery-Dreifuss Syndrome in a Young Patient with a Family History of Dilated Cardiomyopathy
Open Access
- 14 July 2021
- Vol. 12 (7), 1070
- https://doi.org/10.3390/genes12071070
Abstract
Emery–Dreifuss muscular dystrophy (EDMD) is a rare genetic disease that affects the musculoskeletal system, including the heart, causing rhythm disorders and cardiomyopathy, sometimes requiring an implantable cardioverter-defibrillator (ICD) or heart transplantation due to severe heart damage. The case described herein concerns a 16-year-old girl, with grade II obesity, without other known pathological antecedents or cardiac pathology diagnosis given an annual history of cardiological investigations. She was admitted to the Infectious Diseases Department with SARS-CoV-2 virus infection. The anamnesis showed that the cardiological investigations performed in the past were completed due to the medical history antecedents of her sister, who had been diagnosed with dilated cardiomyopathy, having undergone the placement of an ICD and a heart transplant. Numerous investigations were performed during hospitalization, which revealed high levels of high-sensitive cardiac troponin I (hs-cTnI), creatine kinase (CK) and N-terminal pro b-type natriuretic peptide (NT-proBNP). Dynamic electrocardiographic evaluations showed ventricular extrasystoles, without clinical manifestations. The patient presented stage 2 arterial hypertension (AHT) during hospitalization. A cardiac ultrasound was also performed, which revealed suspected mild subacute viral myocarditis with cardiomyopathy, and antihypertensive medication was initiated. A heart MRI was performed, and the patient was diagnosed with dilated cardiomyopathy, refuting the suspicion of viral subacute myocarditis. After discharge, as the patient developed gait disorders with an impossible heel strike upon walking and limitation of the extension of the arms and ankles, was hospitalized in the Neurology Department. Electrocardiograms (ECGs) were dynamically performed, and because the rhythm disorders persisted, the patient was transferred to the Cardiology Department. On Holter monitoring, non-sustained ventricular tachycardia (NSVT) was detected, so antiarrhythmic treatment was initiated, and placement of an ICD was subsequently decided and was diagnosed with EDMD. Genetic tests were also performed, and a mutation of the lamin A/C gene was detected (LMNA gene exon 2, variant c448A > C (p.Thr150pro), heterozygous form, AD).This publication has 10 references indexed in Scilit:
- A Novel EMD Mutation Identified by Whole-Exome Sequencing in Twins with Emery–Dreifuss Muscular DystrophyCase Reports in Genetics, 2020
- Predictores de riesgo en una cohorte española con cardiolaminopatías. Registro REDLAMINARevista Espanola de Cardiologia, 2020
- Emery‐Dreifuss muscular dystrophyMuscle & Nerve, 2019
- The Roles of Human DNA Methyltransferases and Their Isoforms in Shaping the EpigenomeGenes, 2019
- Methods for RNA Modification Mapping Using Deep Sequencing: Established and New Emerging TechnologiesGenes, 2019
- Formins Emerge as a Cause of Hypertrophic CardiomyopathyJournal of the American College of Cardiology, 2018
- Clinical aspects of Emery-Dreifuss muscular dystrophyNucleus, 2018
- Mutations of the FHL1 Gene Cause Emery-Dreifuss Muscular DystrophyAmerican Journal of Human Genetics, 2009
- Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophyJournal of Medical Genetics, 2005